Catheter Precision Inc. (VTAK)
0.46
0.02 (4.55%)
At close: Jan 14, 2025, 3:59 PM
0.47
2.94%
After-hours Jan 14, 2025, 08:00 PM EST
undefined% (undefined)
| Bid | 0.46 |
| Market Cap | 3.68M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 2.78 |
| PE Ratio (ttm) | 0.17 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.47 |
| Volume | 178,776 |
| Avg. Volume (20D) | 3,775,818 |
| Open | 0.44 |
| Previous Close | 0.44 |
| Day's Range | 0.43 - 0.48 |
| 52-Week Range | 0.31 - 8.40 |
| Beta | undefined |
About VTAK
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patie...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 27, 2018
Employees 14
Stock Exchange AMEX
Ticker Symbol VTAK
Next Earnings Release
Catheter Precision Inc. is scheduled to release its earnings on Mar 31, 2025,
after market closes.
Analysts project revenue of $280.00K, reflecting a 118.75% YoY growth and earnings per share of -0.2, making a -80.00% decrease YoY.
Analysts project revenue of $280.00K, reflecting a 118.75% YoY growth and earnings per share of -0.2, making a -80.00% decrease YoY.
2 months ago ·
Source
+10.47%
Catheter Precision shares are trading higher. The ...
Unlock content with
Pro Subscription
2 months ago ·
Source
-29.17%
Catheter Precision shares are trading lower after the company announced it will exercise $4.9 million worth of warrants to purchase 5,347,981 shares of common stock at an exercise price of $0.70.